Thegrio Politics
@thegriopolitics·150K subscribers·8.3K videos
Merck to Seek Emergency Authorization for Pill That Cuts COVID-19 Death Risk in Half
Posted
October 1, 2021
October 1, 2021
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:38Now PlayingMerck and Ridgeback Biotherapeutics said that molnupiravir, a pill.
cuts the risk of hospitalization or death due to COVID-19 in half, citing a study on Friday.
At the interim analysis, molnupiravir reduced the risk of hospitalization or death by approximately 50%. , Merck, via news release.
To watch BNC programming, visit
Follow BNC on social media:
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
